Nonrenal complications of the nephrotic syndrome

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

The nephrotic syndrome is a consequence of urinary loss of intermediate- sized plasma proteins and the resulting homeostatic responses to those losses. Plasma protein composition is changed greatly. Pathophysiologic changes are a consequence of the nature of the proteins lost and of the proteins that are increased in plasma to replace them. Plasma oncotic pressure (π) falls because of the replacement of relatively small plasma proteins by larger ones. Decreased π increases transudation of fluid into the interstitum and favors edema. This is exacerbated by causing renal insensitivity to atrial natriuretic factor (ANF), primary renal sodium retention, and plasma volume expansion. Many proteins lost in the urine, such as erythopoietin and IgG, are not defended by increased synthesis. Their loss may result in reduced immunity, anemia, and endocrinopathies. Albumin synthesis can be increased by dietary protein augmentation; however, urinary protein losses also increase, offsetting any palliative effect of increased albumin synthesis on albumin stores. The synthesis of many other proteins secreted by the liver is also increased, causing an elevation in plasma levels of several large proteins, including lipoproteins and elements of the coagulation cascade. This results in hyperlipidemia and, in conjunction with the urinary loss of smaller proteins that impede coagulation, a hypercoagulable state. Lipoprotein catabolism is also reduced as a consequence of proteinuria contributing to increased lipid levels.

Original languageEnglish (US)
Pages (from-to)201-210
Number of pages10
JournalAnnual Review of Medicine
Volume45
DOIs
StatePublished - 1994

Fingerprint

Nephrotic Syndrome
Proteins
Plasmas
Blood Proteins
Albumins
Coagulation
Lipoproteins
Kidney
Dietary Proteins
Plasma Volume
Atrial Natriuretic Factor
Hyperlipidemias
Proteinuria
Liver
Anemia
Immunity
Edema
Immunoglobulin G
Sodium
Urine

Keywords

  • albumin
  • coagulation
  • edema
  • hepatic hypertrophy
  • hyperlipidemia
  • transcription

ASJC Scopus subject areas

  • Cell Biology
  • Medicine(all)

Cite this

Nonrenal complications of the nephrotic syndrome. / Kaysen, George.

In: Annual Review of Medicine, Vol. 45, 1994, p. 201-210.

Research output: Contribution to journalArticle

@article{0162be267c2a48c3ae50ab61ba7ff7b7,
title = "Nonrenal complications of the nephrotic syndrome",
abstract = "The nephrotic syndrome is a consequence of urinary loss of intermediate- sized plasma proteins and the resulting homeostatic responses to those losses. Plasma protein composition is changed greatly. Pathophysiologic changes are a consequence of the nature of the proteins lost and of the proteins that are increased in plasma to replace them. Plasma oncotic pressure (π) falls because of the replacement of relatively small plasma proteins by larger ones. Decreased π increases transudation of fluid into the interstitum and favors edema. This is exacerbated by causing renal insensitivity to atrial natriuretic factor (ANF), primary renal sodium retention, and plasma volume expansion. Many proteins lost in the urine, such as erythopoietin and IgG, are not defended by increased synthesis. Their loss may result in reduced immunity, anemia, and endocrinopathies. Albumin synthesis can be increased by dietary protein augmentation; however, urinary protein losses also increase, offsetting any palliative effect of increased albumin synthesis on albumin stores. The synthesis of many other proteins secreted by the liver is also increased, causing an elevation in plasma levels of several large proteins, including lipoproteins and elements of the coagulation cascade. This results in hyperlipidemia and, in conjunction with the urinary loss of smaller proteins that impede coagulation, a hypercoagulable state. Lipoprotein catabolism is also reduced as a consequence of proteinuria contributing to increased lipid levels.",
keywords = "albumin, coagulation, edema, hepatic hypertrophy, hyperlipidemia, transcription",
author = "George Kaysen",
year = "1994",
doi = "10.1146/annurev.med.45.1.201",
language = "English (US)",
volume = "45",
pages = "201--210",
journal = "Annual Review of Medicine",
issn = "0066-4219",
publisher = "Annual Reviews Inc.",

}

TY - JOUR

T1 - Nonrenal complications of the nephrotic syndrome

AU - Kaysen, George

PY - 1994

Y1 - 1994

N2 - The nephrotic syndrome is a consequence of urinary loss of intermediate- sized plasma proteins and the resulting homeostatic responses to those losses. Plasma protein composition is changed greatly. Pathophysiologic changes are a consequence of the nature of the proteins lost and of the proteins that are increased in plasma to replace them. Plasma oncotic pressure (π) falls because of the replacement of relatively small plasma proteins by larger ones. Decreased π increases transudation of fluid into the interstitum and favors edema. This is exacerbated by causing renal insensitivity to atrial natriuretic factor (ANF), primary renal sodium retention, and plasma volume expansion. Many proteins lost in the urine, such as erythopoietin and IgG, are not defended by increased synthesis. Their loss may result in reduced immunity, anemia, and endocrinopathies. Albumin synthesis can be increased by dietary protein augmentation; however, urinary protein losses also increase, offsetting any palliative effect of increased albumin synthesis on albumin stores. The synthesis of many other proteins secreted by the liver is also increased, causing an elevation in plasma levels of several large proteins, including lipoproteins and elements of the coagulation cascade. This results in hyperlipidemia and, in conjunction with the urinary loss of smaller proteins that impede coagulation, a hypercoagulable state. Lipoprotein catabolism is also reduced as a consequence of proteinuria contributing to increased lipid levels.

AB - The nephrotic syndrome is a consequence of urinary loss of intermediate- sized plasma proteins and the resulting homeostatic responses to those losses. Plasma protein composition is changed greatly. Pathophysiologic changes are a consequence of the nature of the proteins lost and of the proteins that are increased in plasma to replace them. Plasma oncotic pressure (π) falls because of the replacement of relatively small plasma proteins by larger ones. Decreased π increases transudation of fluid into the interstitum and favors edema. This is exacerbated by causing renal insensitivity to atrial natriuretic factor (ANF), primary renal sodium retention, and plasma volume expansion. Many proteins lost in the urine, such as erythopoietin and IgG, are not defended by increased synthesis. Their loss may result in reduced immunity, anemia, and endocrinopathies. Albumin synthesis can be increased by dietary protein augmentation; however, urinary protein losses also increase, offsetting any palliative effect of increased albumin synthesis on albumin stores. The synthesis of many other proteins secreted by the liver is also increased, causing an elevation in plasma levels of several large proteins, including lipoproteins and elements of the coagulation cascade. This results in hyperlipidemia and, in conjunction with the urinary loss of smaller proteins that impede coagulation, a hypercoagulable state. Lipoprotein catabolism is also reduced as a consequence of proteinuria contributing to increased lipid levels.

KW - albumin

KW - coagulation

KW - edema

KW - hepatic hypertrophy

KW - hyperlipidemia

KW - transcription

UR - http://www.scopus.com/inward/record.url?scp=0028308712&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028308712&partnerID=8YFLogxK

U2 - 10.1146/annurev.med.45.1.201

DO - 10.1146/annurev.med.45.1.201

M3 - Article

C2 - 8198377

AN - SCOPUS:0028308712

VL - 45

SP - 201

EP - 210

JO - Annual Review of Medicine

JF - Annual Review of Medicine

SN - 0066-4219

ER -